BIO-SOURCING, CILOA AND INTRACT PHARMA LAUNCH €3.4M EU PROJECT IN INFLAMMATORY INDICATIONS WITH €1.9M SUBSIDIES FROM EUREKA EUROSTARS

Ciloa will be presenting its disrupting co-agonist, Adiponectin, that boosts all GLP-1RA therapeutic effects on obesity/diabetes/MASH @Swiss Biotech Days 2024 (Basel, April 22-23)

Ciloa speaking @Bio-Europe Spring 2024 (Barcelona, March 18-20)

Ciloa @Innovative Therapies Days 2023 from 12 to 13 October (Besancon, France)

Ciloa @ISEV 2022 from 25 to 29 May (Lyon, France)

Ciloa secures €5 million for biomedicines and vaccines development

Ciloa @France Bioproduction 2021

Ciloa @Vivatech 2021

Ciloa selected in “Sanofi iTech Awards”

CILOA creates its new GMP-compliant production unit